INS and Insulin resistance: Metformin, a biguanide agent that decreases hepatic glucose production and increases peripheral insulin sensitivity, has been used in conjunction with a lifestyle intervention program in T2DM obese adolescents with clinical insulin resistance to achieve weight loss and improve insulin sensitivity [13].